(Q46099773)

English

A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response.

scientific article published on 5 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

based on heuristic

inferred from title

author name string

M W Drummond

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

N Heaney

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J Kaeda

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

F E Nicolini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

R E Clark

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

G Wilson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

P Shepherd

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J Tighe

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

L McLintock

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

5 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1199-1201

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262595%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

https://scigraph.springernature.com/pub.10.1038/leu.2009.43

0 references

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.43

7 January 2021

based on heuristic

inferred from DOI database lookup

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.43

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.43

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.43

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.43

7 January 2021

based on heuristic

inferred from DOI database lookup

The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.43

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46099773&oldid=1762081046"